Trial · NCT03520036
Outcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change From Baseline in Average Daily Time (Minutes) to First Prodromal Symptom Associated With Sunlight Exposure Between Hour Post Sunrise and 1 Hour Pre-Sunset at Week 16. | Baseline (Week 0) and Week 16 | ITT Population | Minutes | MEAN |
| PRIMARY | Change From Baseline in Average Daily Duration (Minutes) of Sunlight Exposure Between 1 Hour Post Sunrise and 1 Hour Pre-Sunset Without Prodromal Symptoms at Week 16 | Baseline (Week 0), and Week 16 | ITT Population | Minutes | MEAN |
| PRIMARY | Change From Baseline in Average Daily Mean Duration (Minutes) of Sunlight Exposure Between 1 Hour Post Sunrise and 1 Hour Pre-Sunset Without Prodromal Symptoms at Week 16 | Baseline (Week 0), and Week 16 | ITT Population | Minutes | MEAN |
| SECONDARY | Total Number of Sunlight Exposure Episodes With Prodromal Symptoms During 16-Week Double-Blind Treatment Period | Week 16 | ITT Population | sunlight exposure episodes | MEAN |
| SECONDARY | Change From Baseline in Average Daily Mean Intensity of Prodromal Symptoms During 16-week Double-blind Treatment Period in 11-point Likert Scale | Baseline (Week 0), and Week 16 | ITT Population | score on a scale | MEAN |
| SECONDARY | Change From Baseline in Average Daily Duration (Minutes) of Prodromal Symptoms at 16-Week Double-Blind Treatment Period | Baseline (Week 0), and Week 16 | ITT Population | Minutes | MEAN |
| SECONDARY | Change From Baseline in Pigmentation as Measured by Melanin Density for Average of 6 Skin Segments at Week 8 and Week 16. | Baseline (Week 0), Week 8, and Week 16 | ITT Population | unitless | MEAN |
| SECONDARY | Percent Change From Baseline in Pigmentation as Measured by Melanin Density for Average of 6 Skin Segments at Week 8 and Week 16. | Baseline (Week 0), Week 8, and Week 16 | ITT Population | percent change | MEAN |
| SECONDARY | Total Number of Pain Events During 16-Week Double-Blind Treatment Period | Week 16 | ITT Population | pain events | MEAN |
| OTHER_PRE_SPECIFIED | Total Number of Sunlight Exposure Episodes | Baseline (Week 0) and Week 16 | |||
| OTHER_PRE_SPECIFIED | Change in Pigmentation as Measured by Melanin Density | Baseline (Week 0) and Week 16 | |||
| OTHER_PRE_SPECIFIED | The Quality of Life as Measured by the Patient Reported Outcomes Measurement Information System (PROMIS) 57 | Baseline (Week 0) and Week 16 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03520036/outcomes